| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000026931 |
| Receipt No. | R000030894 |
| Official scientific title of the study | Randomized double-blind controlled trial of patient-controlled epidural analgesia after gynecological abdominal surgery with levobupivacaine 0.125% or ropivacaine 0.2% |
| Date of disclosure of the study information | 2017/04/10 |
| Last modified on | 2017/10/10 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Randomized double-blind controlled trial of patient-controlled epidural analgesia after gynecological abdominal surgery with levobupivacaine 0.125% or ropivacaine 0.2% | |
| Title of the study (Brief title) | Controlled trial of patient-controlled epidural analgesia after gynecological abdominal surgery with levobupivacaine 0.125% or ropivacaine 0.2% | |
| Region |
|
|
| Condition | |||
| Condition | postoperative pain | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | Comparison of efficacy and safety between lebobupivacaine 0.125% and ropivacaine 0.2% in patient-controlled epidural analgesia after gynecological abdominal surgery. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | Confirmatory |
| Trial characteristics_2 | Pragmatic |
| Developmental phase | Not applicable |
| Assessment | |
| Primary outcomes | Cumulative dose of the 48hour local anesthetic obtained from the mechanical PCA pump |
| Key secondary outcomes | 1.VAS at rest
2.VAS at move 3.use of analgesics 4.PCA push and administration 5.blood pressure lowering 6.moter blockade 7.ambulation |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Parallel |
| Randomization | Randomized |
| Randomization unit | Individual |
| Blinding | Double blind -all involved are blinded |
| Control | Active |
| Stratification | NO |
| Dynamic allocation | NO |
| Institution consideration | |
| Blocking | NO |
| Concealment | Numbered container method |
| Intervention | ||
| No. of arms | 2 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | PCEA using levobupivacaine 0.125% | |
| Interventions/Control_2 | PCEA using ropivacaine 0.2% | |
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Female | |||
| Key inclusion criteria | 1.Elective gynecological abdminal surgery
2.Combination of general anesthesia and epidural anesthesia 3.Age over 20years 4.ASA physical status classification 1 or 2 |
|||
| Key exclusion criteria | 1.Malignant tumor surgery
2.Cesarean section 3.Allergy of the amide-type local anesthetic 4.Contraindication of the epidural anaesthesia 5.History of the neurologic disease 6.Treatment of choronic pain 7.Poorly understand usage of PCEA |
|||
| Target sample size | 120 | |||
| Research contact person | |
| Name of lead principal investigator | Tetsuya Hasegawa |
| Organization | Toho University Omori Medical Center |
| Division name | Department of pharmacy |
| Address | 6-11-1,Omorinishi,Ota-ku,Tokyo |
| TEL | 03-3762-4151 |
| thasegawa@med.toho-u.ac.jp | |
| Public contact | |
| Name of contact person | Tetsuya Hasegawa |
| Organization | Toho University Omori Medical Center |
| Division name | Department of pharmacy |
| Address | 6-11-1,Omorinishi,Ota-ku,Tokyo |
| TEL | 03-3762-4151 |
| Homepage URL | |
| thasegawa@med.toho-u.ac.jp | |
| Sponsor | |
| Institute | Toho University |
| Institute | |
| Department | |
| Funding Source | |
| Organization | None |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000030894 |